Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Lom

18 clinical trials in Lom, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Lom at a glance
18
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Lom

Open in trial search

Obesity+1

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:IBUZATRELVIR
  • Sponsor:Pfizer Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Rheumatoid arthritis

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Synact Pharma ApS
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Lom

What the registry says about research in the country

01 Nephrology Research

Innovative studies focusing on chronic kidney disease and related conditions, investigating combination therapies with baxdrostat and dapagliflozin for patients with concurrent hypertension. Additional research explores treatments for secondary hyperparathyroidism in dialysis patients.

  • CKD Management
  • Hemodialysis Treatments
  • Blood Pressure Control

These trials aim to improve outcomes for patients with kidney-related disorders and associated cardiovascular complications.

02 Infectious Disease Studies

Current research includes investigations of respiratory syncytial virus treatments and COVID-19 therapies, with special attention to pediatric populations. Studies also focus on preventing recurrent Clostridioides difficile infections.

  • Viral Infections
  • Bacterial Infections
  • Prevention Strategies

These investigations aim to develop effective treatments for both common and serious infectious diseases.

03 Rheumatology Initiatives

Advanced research in rheumatoid arthritis treatments, including studies of biosimilar medications and novel therapeutic combinations. Investigations focus on early intervention strategies and DMARD-naïve patients.

  • Early Arthritis Treatment
  • Biosimilar Development
  • Combination Therapies

These clinical trials evaluate new approaches to managing inflammatory joint conditions.

04 Emergency Medicine Studies

Research focusing on urgent medical interventions, including anticoagulation reversal for emergency surgery and treatment of acute bacterial skin infections. Studies emphasize rapid and effective treatment protocols.

  • Surgical Emergency Care
  • Acute Infections
  • Critical Care Management

Trials aim to improve outcomes in time-sensitive medical situations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.